These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9437817)

  • 1. Investigative toxicologic pathology in safety assessment--a commentary.
    Farber E
    Toxicol Pathol; 1997; 25(6):660-1. PubMed ID: 9437817
    [No Abstract]   [Full Text] [Related]  

  • 2. Automated bone marrow analysis in rats--a change in paradigm in toxicologic clinical pathology?
    von Beust B
    Vet Clin Pathol; 2014 Jun; 43(2):121-2. PubMed ID: 24894068
    [No Abstract]   [Full Text] [Related]  

  • 3. A Brief Overview of the STP 35th Annual Symposium on the Basis and Relevance of Variation in Toxicologic Responses.
    Irizarry AR; Gropp KE; Dixon D
    Toxicol Pathol; 2017 Jan; 45(1):52-56. PubMed ID: 27815490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pathology testing recommendations for nonclinical toxicity and safety studies.
    Evans GO
    Toxicol Pathol; 1993; 21(5):513-4. PubMed ID: 8115827
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical pathology testing in toxicity studies.
    Brown G
    Toxicol Pathol; 1992; 20(4):672-3. PubMed ID: 1308629
    [No Abstract]   [Full Text] [Related]  

  • 6. Environmental Protection Agency risk assessment--process and toxicologic pathology.
    Copley MP
    Toxicol Pathol; 1997; 25(1):68-71. PubMed ID: 9061854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lies, damn lies, and reference intervals (or hysterical control values for clinical pathology data).
    Hall RL
    Toxicol Pathol; 1997; 25(6):647-9; discussion 650-1. PubMed ID: 9437812
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies by Bolon et. al.
    Tripathi NK
    Toxicol Pathol; 2010 Dec; 38(7):1167. PubMed ID: 21248324
    [No Abstract]   [Full Text] [Related]  

  • 9. Historical ranges: obfuscating perambulators of statistical graffiti or useful tools?
    Rock MT; Khan KN
    Toxicol Pathol; 1997; 25(6):651-2. PubMed ID: 9437813
    [No Abstract]   [Full Text] [Related]  

  • 10. Digital microscopy imaging and new approaches in toxicologic pathology.
    McCullough B; Ying X; Monticello T; Bonnefoi M
    Toxicol Pathol; 2004; 32 Suppl 2():49-58. PubMed ID: 15503664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the "epigenetic end points in toxicologic pathology and relevance to human health" session of the 2014 Society Of Toxicologic Pathology Annual Symposium.
    Hoenerhoff MJ; Hartke J
    Toxicol Pathol; 2015 Jan; 43(1):98-100. PubMed ID: 25330923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on application of refined morphologic evaluation of the testis to the practice of toxicologic pathology.
    Szczech GM; Russell LD
    Toxicol Pathol; 1997; 25(2):230-7. PubMed ID: 9125783
    [No Abstract]   [Full Text] [Related]  

  • 13. Environmental pathology: new directions and opportunities.
    Mossman BT
    Toxicol Pathol; 1999; 27(2):180-6. PubMed ID: 10207982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scientific and Regulatory Policy Committee Points to Consider: Integration of Clinical Pathology Data With Anatomic Pathology Data in Nonclinical Toxicology Studies.
    Siska W; Schultze AE; Ennulat D; Biddle K; Logan M; Adedeji AO; Arndt T; Aulbach AD
    Toxicol Pathol; 2022 Aug; 50(6):808-826. PubMed ID: 35852467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Society of Toxicologic Pathologists--Japanese Society of Toxicologic Pathology: a long and fruitful partnership.
    Shirai T
    Toxicol Pathol; 1997; 25(6):668-9. PubMed ID: 9437820
    [No Abstract]   [Full Text] [Related]  

  • 16. Food and Drug Administration risk assessment--process and toxicologic pathology.
    Moch RW; Dua PN; Hines FA
    Toxicol Pathol; 1997; 25(1):61-7. PubMed ID: 9061853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nontraditional applications in clinical pathology.
    Jordan HL; Register TC; Tripathi NK; Bolliger AP; Everds N; Zelmanovic D; Poitout F; Bounous DI; Wescott D; Ramaiah SK
    Toxicol Pathol; 2014 Oct; 42(7):1058-68. PubMed ID: 24705882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary: comments on the cell death nomenclature recommendations of the Society of Toxicologic Pathologists.
    Mohr U
    Toxicol Pathol; 1999; 27(4):497. PubMed ID: 10485841
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of the toxicologic pathologist in the biopharmaceutical industry.
    van Tongeren S; Fagerland JA; Conner MW; Diegel K; Donnelly K; Grubor B; Lopez-Martinez A; Bolliger AP; Sharma A; Tannehill-Gregg S; Turner PV; Wancket LM
    Int J Toxicol; 2011 Oct; 30(5):568-82. PubMed ID: 21878555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary: implementation of the STP recommendations on the nomenclature of cell death. Society of Toxicologic Pathologists.
    Levin S
    Toxicol Pathol; 1999; 27(4):491. PubMed ID: 10485837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.